Medical Device News Magazine

Empowering Netflix Series ‘Skin Decision: Before and After’ Scores 2021 Emmy Nomination for Its Debut Season

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

On the heels of its debut season, Netflix’s original medical/lifestyle reality show Skin Decision: Before and After has received a 2021 Emmy nomination for “Outstanding Lifestyle Series.” The series takes a unique approach to its genre, as it seeks to bring healing, confidence, and self-empowerment to people who have endured traumatic and life-altering experiences.

Featuring board-certified plastic surgeon Dr. Sheila Nazarian, Skin Decision goes beyond superficial appearances and highlights the beauty within each patient while sharing intimate and emotional stories of real-life people who have suffered everything from confidence-crushing relationships to near-fatal car crashes.

When this project came up, I was so excited to get involved. I really wanted to make a new kind of plastic surgery show. Not a circus. Not demeaning to patients,” Nazarian says. “With this show, we really elevated plastic surgery and aesthetic treatments and showed the very real reasons why people get work done. Also, we showed that looking better can make people feel better and do better.”

Though future plans for the show have yet to be disclosed, Dr. Nazarian has many other accomplishments in sight. In addition to running her private practice in Beverly Hills, she will be expanding into Lake Tahoe soon with Spa26& Nazarian Plastic Surgery. Her non-profit, Nazarian Institute and ThinkBIG!, is growing to include surgical education and techniques for other board-certified plastic surgeons. Her ecommerce site The Skin Spot is ready for its re-launch with the new Skin Quiz, curated medical-grade skincare product offerings, Loyalty Points, and a sampling program. She also intends to continue her activism work to end racism against Jews all around the world.

The full series of Skin Decision: Before and After is available on Netflix. The 2021 Emmy Awards will be broadcast on Sept. 19, 2021, on CBS.

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”